4) Pelleymounter M.A., Cullen M.J., Baker M.B. et al:Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269; 540-543.
7) Haque M.S., Minokoshi Y., Hamai M. et al:Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 1999; 48; 1706-1712.
9) Tartaglia L.A., Dembski M., Weng X. et al:Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83; 1263-1271.
15) Vaisse C., Halaas J.L., Horvath C.M. et al:leptin activation of stat 3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14; 95-97.
16) Banks W.A.:Leptin transport across the blood-brain barrier:implications for the cause and treatment of obesity. Curr Pharm Des 2001; 7; 125-133.
19) Morimoto A., Murakami N:[14C]deoxyglucose incorporation in to rat brain reginos during hypothalamic or peripheral thermal stimulation. Am J Physiol Regul Integr Comp Physiol 1985; 248; R84-R92.
22) DeFronzo R.A., Jacot E., Jequier E. et al:The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30;1000-1007.
23) Hynes W.G., Morgan D.A., Walsh S.A. et al:Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100; 270-278.
24) Scarpace P.S., Matheny M., Pollock B.H. et al:Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol Endocrinol Metab 1997; 273; E226-E230.
25) Elmquist J.K., Bjorbaek C., Ahima R.S. et al:Distribution of leptin receptor mRNA isoforms in the rat brain. J Com Neurol 1998;395;535-547.
26) Ogawa Y., Masuzaki H., Hosoda K. et al:Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 1999; 48; 1822-1829.
27) Shimomura I., Hammer R., Ikemoto S. et al:Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nautre 1999; 401; 73-76.
28) Lin C., Higginbotham A., Judd R.L. et al:Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2002; 282;E1084-E1091.
29) Oarl A.E., Simha V., Ruiz E. et al:Leptin-replacement therapy for lipodystrophy. N Eng J Med 2002; 8; 570-578.
30) Peterson K.F., Oral E.A., Dufour S. et al:Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002; 109; 1345-1350.
31) Halaas J.L, Gajiwaka K.S. Mafei M. et al:Weight reducing effects of the plasma protein encoded by he obese gene. Science 1995; 269; 543-546.
32) Haw J.J., Ghibaudi L., Compton D. et al:Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice. Horm Metab Res 1996; 28; 659-663.
42) Hayashi T., Jogen F.P., Wojtaszewski J.F.P.et al:Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 1997; 273; E1039-E1051.
44) Musi N., Hayashi T., Fugii N. et al:AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 2001; 280;E677-E684.
46) Kurth-Kraczek J.E., Hirshman M.F., Goodyear L.J. et al:5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999; 48; 1667-1671.
47) Hayashi T., Hirshman M.F., Kurth E.J. et al:Evidence for 5' AMP activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47; 1369-1373.
49) Iglesias M.A., Ye J.M., Frangioudakis G. et al:AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant highfat-fed rats. Diabetes 2002; 51; 2886-2894.
50) Vavvas D., Apazidis A., Saha A.K. et al:Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem 1997; 272; 13256-13261.
52) Terada S., Goto M., Kato M. et al:Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 2002; 296; 350-354.
53) Mu J., Brozinick J.T. Jr., Valladares O. et al:A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001; 7; 1085-1094.
54) Derave W., Ai H., Ihlemann J. et al:Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 2000; 49; 1281-1287.
56) Oakes N.D., Kjellstedt A., Forsberg G-B. et al:Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res 1999; 40; 1155-1169.
57) Unger R.H., Zhou Y-T., Orci L. et al:Regulation of fatty acid homeostasis in cells:novel role of leptin. Proc Natl Acad Sci USA 1999; 96; 2327-2332.
58) Steinberg G.R., Rush J.W.E., Dyck D.J. et al:AMPK. expression and phosphorylation are increased in rodent muscle following chronic leptin treatment. Am J Physiol Endocrinol Metab 2002;284;E648-E654.
59) Muoio D.M., Dohm G.L., Fiedoreck F.T.Jr. et al:Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997; 46; 1360-1363.
60) Zierath J.R., Frevert E.U., Ryder J.W. et al:Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 1998; 47;1-4.
61) Steinberg G.R., Parolin M.L., Heigenhauser G.J.F. et al:Leptin increases FA oxidation in lean but not obese human skeletal muscle:evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 2002; 283; E187-E192.